Holen Sie sich die Stockscreener-App
0.00
82.02%
-10.62
Handel nachbörslich:
2.51
2.51
+
Schlusskurs vom Vortag:
$10.62
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
Marktkapitalisierung:
$182.54M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
0.00
EPS:
1.1108
Netto-Cashflow:
-
1W Leistung:
-82.02%
1M Leistung:
-82.02%
6M Leistung:
-82.02%
1J Leistung:
-82.02%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$2.30
$2.505
52-Wochen-Spanne:
$2.30
$2.505
Accendra Health Inc Stock (ACH) Company Profile
Firmenname
Accendra Health Inc
Sektor
Branche
Telefon
(804) 723-7000
Adresse
10900 NUCKOLS ROAD, GLEN ALLEN
Vergleichen Sie ACH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ACH
Accendra Health Inc
|
0.00 | 182.54M | 0 | 0 | 0 | 0.00 |
|
MCK
Mckesson Corporation
|
816.06 | 100.55B | 387.09B | 4.23B | 6.01B | 32.12 |
|
COR
Cencora Inc
|
335.69 | 65.13B | 321.33B | 1.57B | 3.21B | 7.9518 |
|
CAH
Cardinal Health Inc
|
201.11 | 48.11B | 234.31B | 1.61B | 4.45B | 6.6243 |
|
HSIC
Henry Schein Inc
|
77.64 | 9.30B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.38 | 730.44M | 2.22M | -5.63M | -1.68M | -0.24 |
Accendra Health Inc Stock (ACH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-03 | Herabstufung | UBS | Buy → Neutral |
| 2024-07-19 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2022-10-13 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-10-12 | Herabstufung | BofA Securities | Buy → Underperform |
| 2022-10-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-04-26 | Fortgesetzt | Citigroup | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2022-03-30 | Fortgesetzt | JP Morgan | Underweight |
| 2022-03-23 | Hochstufung | HSBC Securities | Reduce → Hold |
| 2021-04-08 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-03-08 | Hochstufung | Goldman | Sell → Buy |
| 2020-12-17 | Hochstufung | UBS | Neutral → Buy |
| 2020-09-25 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2020-07-21 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-07-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-07-14 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-05-05 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-04-23 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-01-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-01-07 | Herabstufung | Goldman | Neutral → Sell |
| 2019-11-15 | Hochstufung | CLSA | Underperform → Outperform |
| 2019-09-06 | Bestätigt | BofA/Merrill | Neutral |
| 2019-04-10 | Bestätigt | BofA/Merrill | Neutral |
| 2019-04-03 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-04-01 | Hochstufung | JP Morgan | Underweight → Overweight |
| 2019-01-18 | Hochstufung | HSBC Securities | Hold → Buy |
| 2019-01-17 | Eingeleitet | UBS | Neutral |
| 2019-01-15 | Hochstufung | CLSA | Underperform → Outperform |
| 2018-12-14 | Herabstufung | Morgan Stanley | Overweight → Underweight |
| 2018-12-12 | Herabstufung | Goldman | Buy → Neutral |
| 2018-09-28 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-11 | Herabstufung | CLSA | Outperform → Sell |
| 2018-04-10 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2018-03-26 | Hochstufung | Goldman | Sell → Neutral |
| 2017-11-02 | Herabstufung | HSBC Securities | Buy → Hold |
| 2016-03-24 | Hochstufung | Goldman | Sell → Neutral |
| 2015-12-07 | Herabstufung | Goldman | Neutral → Sell |
| 2015-08-31 | Hochstufung | Credit Suisse | Underperform → Neutral |
| 2012-08-01 | Eingeleitet | HSBC Securities | Underweight |
| 2009-08-05 | Hochstufung | Citigroup | Sell → Buy |
| 2008-12-01 | Herabstufung | HSBC Securities | Neutral → Underweight |
Alle ansehen
Accendra Health Inc Aktie (ACH) Neueste Nachrichten
Accendra Health (ACH): Citigroup Lowers Price Target, Maintains Buy Rating | ACH Stock News - GuruFocus
Implied Volatility Surging for Accendra Health Stock Options - sharewise.com
Gree Says Won’t Hike Air-Con Prices, Swap Copper for Aluminum Despite Metal’s Surging Cost - Yicai Global
China Metals & Mining Industry Report 2025, Profiles of Jiangxi Copper, China Shenhua Energy Co, Zijin Mining Group, Aluminum Corp of China - Yahoo Finance
"Post-70s" Lu Dongliang became Vice Governor of Shanxi Province before becoming Chairman of Aluminum Corporation of China - Shanghai Metals Market
Owens & Minor Completes Sale of Products & Healthcare Services Business to Platinum Equity - citybiz
Chalco’s Stock Tests Investor Nerves As Aluminum Cycle Turns: Is The Worst Finally Priced In? - AD HOC NEWS
Alcoa Corp Is Popping Off: Is AA Stock a Sleepy Boomer Metal Play or a Sneaky Viral Win? - AD HOC NEWS
Accendra Health begins trading on NYSE under new ticker symbol By Investing.com - Investing.com Nigeria
Platinum Equity Completes Acquisition of Owens & Minor Products & Healthcare Services Business - Platinum Equity
Owens & Minor rebrands after $375M sale of largest division - Virginia Business
Two new option listings and three option delistings on January 2nd - TipRanks
Aluminum Smelting Market Set for Rapid Growth |Alcoa - openPR.com
Platinum Equity Completes Acquisition Of Owens & Minor Products & Healthcare Services Business - Pulse 2.0
Accendra Health Begins Trading Under 'ACH' Ticker After Owens & Minor Divestment - MarketScreener
Accendra Health begins trading on NYSE under new ticker symbol - Investing.com
Accendra Health to Begin Trading on NYSE under New Ticker “ACH” - TradingView — Track All Markets
Accendra Health, Inc. to Begin Trading on NYSE under New Ticker “ACH” - FinancialContent
Accendra Health, Inc. to Begin Trading on NYSE under New Ticker "ACH" - Yahoo Finance
Owens & Minor, Inc. will Change its Ticker to ACH from OMI - MarketScreener
Owens & Minor completes sale of products segment, rebrands as Accendra - Investing.com Nigeria
Owens & Minor completes sale of products & healthcare services business to Platinum Equity - MarketScreener
Owens & Minor Completes Sale, Transforms to Accendra Health - TipRanks
Accendra Health Signs Multiple Financing Agreements - TradingView — Track All Markets
Owens & Minor (NYSE: OMI) closes $375M P&HS sale and adopts Accendra Health name - Stock Titan
Owens & Minor, Inc. Completes Sale of Products & Healthcare Services Business to Platinum Equity - Business Wire
Aluminum Market 2025 | Industry Growth, Investment Opportunities, Key Players, Share 2025 - openPR.com
Owens & Minor, Inc. will Change its Name to Accendra Health, Inc - MarketScreener
Aluminum Corporation of China Updates Capital Structure for New Chinalco-Led Joint Venture - TipRanks
Aluminum Corporation of China Shareholders Approve All Resolutions at Third 2025 EGM - TipRanks
Primary Aluminum Market set for steady growth to US$152.85 - openPR.com
Chalco Clears Conditions for Yunnan Aluminum’s Minority Stake Acquisition in Three Subsidiaries - TipRanks
Owens & Minor to change name on Dec. 31 - Virginia Business
Owens & Minor: Debt Limits Recovery Potential (Upgrade) (NYSE:ACH) - Seeking Alpha
CHALCO unwraps phase 2 of the 2021 restricted share incentive programme - alcircle
CHALCO to Yunnan Aluminum Foil – completion of capital agreement - alcircle
Rolled Aluminum Products Market to Reach US$80.77Bn by 2032 | Automotive & EV Lightweighting Drive 7.59% CAGR - openPR.com
Guinea, EGA in bauxite supply deal talks - Mining.com
Aluminum of China Advances with 2021 Share Incentive Unlocking - TipRanks
Chalco Completes Capital Contribution to Yunnan Aluminum Foil - TipRanks
Construction Aluminum Market is expected to reach - openPR.com
Owens & Minor names Bernocchi EVP & COO - HME News
Trump tariffs live updates: Bessent confirms China on track to keep trade deal; OECD upgrades US growth forecast - Yahoo Finance UK
Chalco Announces New Resolution for Upcoming EGM - TipRanks
Trump tariffs live updates: US growth forecast rises despite Trump tariffs; Lutnick confirms S. Korea's 15% tariff rate - Yahoo Finance UK
Owens & Minor to Present at Upcoming Investor Conferences on December 2, 2025 - Business Wire
United States Industrial Aluminum Market 2025-2032 | Growth Drivers, Key Players & Investment Opportunities - openPR.com
From Europe to Asia, aluminium’s downstream sector hits a week of defining changes and here’s everything you need to know - alcircle
Chalco to Host Online Briefing on Q3 2025 Results and Future Strategies - TipRanks
Hong Kong Stock Movement | Chalco (02600) Opens Over 4% Higher as It Plans to Acquire Equity Stakes in Three Subsidiaries, Including Yunnan Aluminium Yongxin, to Strengthen Core Business Strategy - 富途牛牛
Aluminum of China to Repurchase and Cancel Restricted Shares - TipRanks
Finanzdaten der Accendra Health Inc-Aktie (ACH)
Es liegen keine Finanzdaten für Accendra Health Inc (ACH) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Accendra Health Inc-Aktie (ACH) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Coliseum Capital Management, L | 10% Owner |
Aug 14 '25 |
Buy |
5.31 |
492,852 |
2,617,044 |
13,100,807 |
| Coliseum Capital Management, L | 10% Owner |
Aug 13 '25 |
Buy |
5.46 |
325,000 |
1,774,500 |
12,607,955 |
| Coliseum Capital Management, L | 10% Owner |
Apr 09 '25 |
Buy |
7.39 |
225,000 |
1,662,750 |
11,482,955 |
| Coliseum Capital Management, L | 10% Owner |
Apr 08 '25 |
Buy |
7.96 |
105,000 |
835,800 |
11,257,955 |
| Coliseum Capital Management, L | 10% Owner |
Apr 10 '25 |
Buy |
7.19 |
80,000 |
575,200 |
11,562,955 |
| Coliseum Capital Management, L | 10% Owner |
Apr 07 '25 |
Buy |
7.84 |
240,000 |
1,881,600 |
11,152,955 |
| Coliseum Capital Management, L | 10% Owner |
Apr 03 '25 |
Buy |
8.53 |
160,000 |
1,364,800 |
10,784,599 |
| Coliseum Capital Management, L | 10% Owner |
Apr 04 '25 |
Buy |
8.14 |
128,356 |
1,044,818 |
10,912,955 |
| Coliseum Capital Management, L | 10% Owner |
Feb 28 '25 |
Buy |
9.39 |
1,738,511 |
16,324,618 |
9,469,698 |
| Coliseum Capital Management, L | 10% Owner |
Mar 04 '25 |
Buy |
9.75 |
800,000 |
7,800,000 |
10,624,599 |
0.28%
8.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):